Get Prostate Cancer Research Program Funding Opportunities Archives ...

Stereotactic body radiation therapy (SBRT) SBRT might be an option to treat some cancers that are just in the prostate. The main advantage of SBRT over IMRT in this setting is that the treatment takes much less time (days instead of weeks).

Early Investigator Research Awards support prostate cancer-focused research opportunities for individuals in the early stages of their careers under the guidance of one or more designated mentors. DoD Early Investigator Research Award in Prostate Cancer Research unthsc.edu https://.unthsc.edu › daily-news › dod-early-investi... unthsc.edu https://.unthsc.edu › daily-news › dod-early-investi...

Researchers are looking at newer forms of treatment for early-stage prostate cancer. These new treatments might be used either as the first treatment or if cancer remains after radiation therapy. For example, doctors are now looking at whether ablative treatments can be helpful for these cancers. What's New in Prostate Cancer Research? cancer.org https://.cancer.org › types › prostate-cancer › about cancer.org https://.cancer.org › types › prostate-cancer › about

Since 1997, the Prostate Cancer Research Program (PCRP) has been dedicated to supporting research focused on eradicating prostate cancer, and specifically seeks to promote: Highly innovative, groundbreaking research. High-impact research with near-term clinical relevance. Prostate Cancer Research Program, Congressionally Directed Medical ... health.mil https://cdmrp.health.mil › pcrp health.mil https://cdmrp.health.mil › pcrp

Purpose: The FY23 PCRP Idea Development Award is intended to support new ideas that represent innovative approaches to prostate cancer research and have the potential to make an important contribution to the PCRP Mission. DoD Prostate Cancer Research Program - Stanford Medicine Stanford Medicine https://med.stanford.edu › rmg › funding › PCRP Stanford Medicine https://med.stanford.edu › rmg › funding › PCRP

Exablate Prostate, developed by the health care technology company Insightec, uses high-intensity sound waves, or ultrasound, to target and destroy cancer cells within the prostate while leaving surrounding healthy tissues unaffected.

A biopsy is the main tool for diagnosing prostate cancer, but a doctor can use other tools to help make sure the biopsy is made in the right place. For example, doctors may use transrectal ultrasound or magnetic resonance imaging (MRI) to help guide the biopsy.

FDA approves for non-metastatic castration-sensitive prostate cancer with biochemical recurrence. On November 16, 2023, the Food and Drug Administration approved (, Astellas Pharma US, Inc.)